AstraZeneca
LSE:AZN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 149 Fair Values set on narratives written by author
WA
Consensus Narrative from 20 Analysts
Delivering 20 New Medicines By 2030 Will Strengthen Future Prospects
Key Takeaways AstraZeneca's strong pipeline and transformative technologies are set to boost long-term revenue and net margins significantly. Manufacturing expansion and emerging market growth are poised to meet product demand and sustain future revenue growth.
View narrativeUK£140.00
FV
16.4% undervalued intrinsic discount6.08%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
New narrative